Dean M. Kirkel, MD joined Northwest Georgia Oncology Centers in December 2013. He completed his internship and residency at St. Mary’s Health Center / St. Louis University in St. Louis, MO in 2004. Following his residency Dr. Kirkel served as a junior faculty member in the Department of Medicine at Washington University in St. Louis where he was responsible for patient management and resident teaching in general medicine and oncology. Upon completion of his fellowship at George Washington University Medical Center in Washington, D.C. in 2009, Dr. Kirkel treated patients in private practice in Boynton Beach, FL.
Dr. Kirkel has a clinical interest in lymphomas, plasma cell disorders, breast cancer, clotting disorders, and gastrointestinal neoplasia. He is actively involved in cancer research and clinical trials to find a cancer cure and provide his patients with the most advanced cancer treatment available in Georgia as a Principal Investigator of the William S. Gibbons Cancer Research Institute.
He provides patient-centered cancer care at NGOC’s Marietta Cancer Center.
|Personal Data||Birthplace: Johannesburg, South Africa|
|Medical Education||Doctor of Medicine
University of Witwatersrand Medical School
Johannesburg, South Africa
|Postdoctoral Training||INTERNSHIP AND RESIDENCY
St. Mary's Health Center, St. Louis University
St. Louis, MO
December 2001 - November 2004
Hematology and Medical Oncology
George Washington University Medical Center
July 2006 – June 2009
|Board Certification||American Board of Internal Medicine, Medical Oncology, 2009
American Board of Internal Medicine, Hematology, 2009
American Board of Internal Medicine, Internal Medicine, 2015
|Medical Licensure||State of Georgia (Active)
|Professional Societies||American Society of Clinical Oncology
American Society of Hematology
Alpha Omega Alpha Medical Honors Society
|Publications||Multiple Bony Amyloidomas as an Initial Presentation of Myeloma - Clinical Lymphoma Myeloma. 2009, Oct; 9(5): E18-20.
Asymptomatic Factor VII Deficiency - Gene Analysis and Structure-Function Relationships - Blood Coagulation & Fibrinolysis. 21(1): 91-94, January 2010.
Subclinical C-HUS and Complete Remission in Metastatic Gastric Cancer Treated with C-MAX. Journal of Clinical Oncology, 28, (suppl; abstr e14657).
O-Max Chemotherapy: High Activity in Metastatic Esophagogastric Adenocarcinoma and possible relation to Subclinical Hemolysis. Oncology 2014; 87: 371-380.
|Major Research Interests||Clinical Trials (Oncology & Hematology)|